BlackBarn Capital Partners »

Amneal Pharmaceuticals shares owned by BlackBarn Capital Partners

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by BlackBarn Capital Partners from 13F filings

Historical chart of BlackBarn Capital Partners investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by BlackBarn Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by BlackBarn Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $22M 2.2M 10.01
2025-06-30 $28M 3.4M 8.09
2025-03-31 $24M 2.9M 8.38
2024-12-31 $23M 2.9M 7.92
2024-09-30 $20M 2.4M 8.32
2024-06-30 $13M 2.0M 6.35
2024-03-31 $8.6M 1.4M 6.06

More positions owned by BlackBarn Capital Partners

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
ResMed Put Option (RMD)
Roivant Sciences SHS (ROIV)
Warby Parker Cl A Com Put Option (WRBY)
Privia Health Group (PRVA)
Diversified Healthcare Tr Com Sh Ben Int (DHC)
Nextracker Class A Com (NXT)
Oscar Health Cl A Put Option (OSCR)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Nextera Energy (NEE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Axcelis Technologies Com New (ACLS)
Molina Healthcare (MOH)
Elanco Animal Health Put Option (ELAN)
Cogent Communications Hldgs Com New (CCOI)

View all positions for BlackBarn Capital Partners

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
Nantahala Capital Management
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Millennium Management
Nuveen
Acadian Asset Management
Morgan Stanley
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals